Innoveix Recalls Lyophilized Chorionic Gonadotropin Due to Sterility Concerns
Innoveix Pharmaceuticals is recalling 3,905 vials of Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection due to a lack of sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an injectable medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Innoveix Pharmaceuticals Inc is recalling 3,905 vials of Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection. The recall is being conducted because of a lack of sterility assurance in the product.
The affected product is a prescription-only medication compounded by Innoveix in Addison, Texas. The recall covers specific lots with expiration dates ranging from November 2019 to July 2020. The product was distributed nationwide within the United States.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
- Manufacturer
- Innoveix Pharmaceuticals Inc
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 3,905
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: INX 530 Exp. 11/6/19
- INX 535 Exp. 11/15/19
- INX 540 Exp. 2/1/20
- INX 545 Exp. 2/15/20
- INX 550 Exp. 3/9/20
- INX 555 Exp. 3/26/20
- INX 560 Exp. 5/3/20
- INX 565 Exp. 5/18/20
- INX 570 Exp. 6/28/20
- INX 575 Exp. 7/18/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Innoveix Pharmaceuticals Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Innoveix Pharmaceuticals Inc
See all →- SevereCompounded Lyophilized AOD-9604 Injection Recalled for Sterility Risk
FDA (Drugs) · 2021-07-28
- SevereCompounded Semorelin/Ipamorelin Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-07-28
- SevereInnoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15